Search Results - "Kenemans, P."

Refine Results
  1. 1

    Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group by Kenemans, P, Speroff, L

    Published in Maturitas (16-05-2005)
    “…An international multidisciplinary panel of experts in the management of the menopause met at the 4th Amsterdam Menopause Symposium in October 2004 to…”
    Get full text
    Journal Article
  2. 2

    Therapeutic options for postmenopausal female sexual dysfunction by Al-Azzawi, F., Bitzer, J., Brandenburg, U., Castelo-Branco, C., Graziottin, A., Kenemans, P., Lachowsky, M., Mimoun, S., Nappi, R. E., Palacios, S., Schwenkhagen, A., Studd, J., Wylie, K., Zahradnik, H.-P.

    “…Background Female sexual dysfunction (FSD) is a multidimensional problem combining biological, psychological and interpersonal elements of multiple etiologies…”
    Get full text
    Journal Article
  3. 3

    Survival in Early Breast Cancer Patients Is Favorably Influenced by a Natural Humoral Immune Response to Polymorphic Epithelial Mucin by VON MENSDORFF-POUILLY, S, VERSTRAETEN, A. A, KENEMANS, P, SNIJDEWINT, F. G. M, KOK, A, VAN KAMP, G. J, PAUL, M. A, VAN DIEST, P. J, MEIJER, S, HILGERS, J

    Published in Journal of clinical oncology (01-02-2000)
    “…Polymorphic epithelial mucin (PEM or MUC1) is being studied as a vaccine substrate for the immunotherapy of patients with adenocarcinoma. The present study…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Breast cancer and post-menopausal hormone therapy by Kenemans, P, Bosman, A

    “…From the introduction of post-menopausal hormone replacement therapy (HRT) there has been great concern that HRT could possibly increase the risk of breast…”
    Get full text
    Journal Article
  6. 6

    Oncogenic pathways in hereditary and sporadic breast cancer by Kenemans, P, Verstraeten, R A, Verheijen, R H M

    Published in Maturitas (01-09-2008)
    “…Cancer is a genetic disease. Breast cancer tumorigenesis can be described as a multi-step process in which each step is thought to correlate with one or more…”
    Get full text
    Journal Article
  7. 7

    Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo‐controlled study by VERHOEVEN, M. O., HEMELAAR, M., MOOREN, M. J. VAN DER, KENEMANS, P., TEERLINK, T.

    Published in Journal of internal medicine (01-02-2006)
    “… Objective.  To compare the effects of oral and transdermal hormone therapy (HT) on asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric…”
    Get full text
    Journal Article
  8. 8

    Estrogenic uterovaginal effects of oral estetrol in the modified Allen-Doisy test by Heegaard, A.-M., Holinka, C. F., Kenemans, P., Coelingh Bennink, H. J. T.

    “…Objective To evaluate the effect of estetrol (E4) on vaginal cornification and uterine wet weight in the ovariectomized rat. Methods Adult female rats served…”
    Get full text
    Journal Article
  9. 9

    Emerging selective estrogen receptor modulators : Special focus on effects on coronary heart disease in postmenopausal women by VOGELVANG, Tatjana Elène, VAN DER MOOREN, Marius Jan, MIJATOVIC, Velja, KENEMANS, Peter

    Published in Drugs (New York, N.Y.) (01-01-2006)
    “…Menopause, regardless of age at onset, is associated with a marked increase in coronary heart disease (CHD) risk. On the basis of epidemiological studies that…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Histopathologic Features of Genetically Determined Ovarian Cancer by Shaw, P A, McLaughlin, J R, Zweemer, R P, Narod, S A, Risch, H, Verheijen, R H. M, Ryan, A, Menko, F H, Kenemans, P, Jacobs, I J

    “…Inheritance of germline mutations of BRCA1 or BRCA2 genes account for approximately 10% of ovarian carcinomas, but the characterization of these genetically…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Effects of transdermal and oral oestrogen replacement therapy on C-reactive protein levels in postmenopausal women: a randomised, placebo-controlled trial by Post, M S, van der Mooren, M J, Stehouwer, C D A, van Baal, W M, Mijatovic, V, Schalkwijk, C G, Kenemans, P

    Published in Thrombosis and haemostasis (01-10-2002)
    “…To investigate the effect of postmenopausal oral and transdermal hormone therapy on plasma levels of C-reactive protein (CRP), we performed a randomised,…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Oncogenic pathways in hereditary and sporadic breast cancer by Kenemans, P., Verstraeten, R.A., Verheijen, R.H.M.

    Published in Maturitas (24-09-2004)
    “…Cancer is a genetic disease. Breast cancer tumorigenesis can be described as a multi-step process in which each step is thought to correlate with one or more…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Reprint of Oncogenic pathways in hereditary and sporadic breast cancer by Kenemans, P, Verstraeten, R.A, Verheijen, R.H.M

    Published in Maturitas (2008)
    “…Abstract Cancer is a genetic disease. Breast cancer tumorigenesis can be described as a multi-step process in which each step is thought to correlate with one…”
    Get full text
    Journal Article
  17. 17

    PCR‐based high‐risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears by Rozendaal, L., Walboomers, J.M.M., van der Linden, J.C., Voorhorst, F.J., Kenemans, P., Helmerhosrt, Th.J.M., van Ballegooijen, M., Meijer, C.J.L.M.

    Published in International journal of cancer (11-12-1996)
    “…Cervical‐cancer screening programmes using cytomorphological criteria could be more efficient if the screening included objective individual risk factors for…”
    Get full text
    Journal Article
  18. 18

    Less mammographic density after nasal versus oral administration of postmenopausal hormone therapy by van Dijck, J. A. A. M., Otten, J. D. M., Karssemeijer, N., Kenemans, P., Verbeek, A. L. M., van der Mooren, M. J.

    “…ABSTRACT Objective Nasal administration gives a more acute but shorter rise in serum hormone levels than oral administration and may therefore have less effect…”
    Get full text
    Journal Article
  19. 19

    Tibolone: Clinical recommendations and practical guidelines by Kenemans, P., Speroff, L.

    Published in Maturitas (01-05-2005)
    “…An international multidisciplinary panel of experts in the management of the menopause met at the 4th Amsterdam Menopause Symposium in October 2004 to…”
    Get full text
    Journal Article
  20. 20

    Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation by Hermsen, B.B.J, Verheijen, R.H.M, Menko, F.H, Gille, J.J.P, van Uffelen, K, Blankenstein, M.A, Meijer, S, van Diest, P.J, Kenemans, P, von Mensdorff-Pouilly, S

    Published in European journal of cancer (1990) (01-07-2007)
    “…Abstract Introduction Breast cancer patients with early disease and a natural humoral response to MUC1 have a favourable prognosis, suggesting a possible role…”
    Get full text
    Journal Article